M

Michelle Luo

University of North Carolina at Chapel Hill

ORCID: 0000-0003-2817-4208

92 papers and 856 citations.

PubIndex Score94Top 6% · mid-careerHow it's scored

92Publications

856Total Citations

First senior author: 2016

Top publicationsby citations

Effectiveness and safety of vedolizumab and infliximab in biologic-naive patients with Crohn’s disease: results from the EVOLVE study

Gerassimos J. Mantzaris, Andrés Yarur, Sumit Saha et al.|European Journal of Gastroenterology & Hepatology|2023

Cited by 9

DOP60 Simplified rules to identify bio-naïve patients with Crohn’s Disease with higher likelihood of clinical remission when initiating vedolizumab versus anti-TNFα therapies: Analysis of EVOLVE study data

Gerassimos J. Mantzaris, Brian Bressler, Andrés Yarur et al.|Journal of Crohn s and Colitis|2021

Cited by 7

DOP55 A real-world comparison of the effectiveness and safety of vedolizumab and anti-TNF therapies in early treatment initiation with first-line biologic therapy in ulcerative colitis: Results from EVOLVE

Gerassimos J. Mantzaris, Andrés Yarur, Shu Wang et al.|Journal of Crohn s and Colitis|2020

Cited by 4

Indexing the rest of 92 publications…